Eagle Bay Advisors LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eagle Bay Advisors LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$685
-36.2%
2160.0%0.00%
-100.0%
Q2 2023$1,074
+101.1%
216
+100.0%
0.00%
Q1 2023$534
-21.4%
1080.0%0.00%
Q4 2022$679
-32.1%
1080.0%0.00%
-100.0%
Q3 2022$1,000
-99.9%
1080.0%0.00%0.0%
Q2 2022$1,231,000
+61450.0%
1080.0%0.00%0.0%
Q4 2021$2,000
-33.3%
1080.0%0.00%
-50.0%
Q3 2021$3,0000.0%1080.0%0.00%0.0%
Q2 2021$3,0001080.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders